Burford Capital (BUR LN) Petersen v Argentina positive developments | Low & Bonar (LWB LN) Tough H1 | ReNeuron Group (RENE LN) Exclusivity deal in ophthalmology, licensing deal expected in 2018 | Safestyle UK (SFE LN) Turnaround well underway but additional hit to profits and cash | Summit Therapeutics (SUMM LN) Grant award from CARB-X to support gonorrhoea programme | Swallowfield (SWL LN) Strong growth in Brands mitigates Manufacturing

11 Jul 2018
Morning Song
Burford Capital Limited (BUR:LON), 874 | Low & Bonar (LWB:LON), 0 | ReNeuron Group plc (RENE:LON), 26.0 | Safestyle UK Plc (SFE:LON), 38.0 | Summit Therapeutics (SUMM:LON), 0 | Brand Architekts Group plc (BAR:LON), 50.0
-
-
-
N+1 Singer Team
-
13 pages
-


Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Song
Burford Capital Limited (BUR:LON), 874 | Low & Bonar (LWB:LON), 0 | ReNeuron Group plc (RENE:LON), 26.0 | Safestyle UK Plc (SFE:LON), 38.0 | Summit Therapeutics (SUMM:LON), 0 | Brand Architekts Group plc (BAR:LON), 50.0
- Published:
11 Jul 2018 -
Author:
N+1 Singer Team -
Pages:
13 -
Burford Capital (BUR LN) Petersen v Argentina positive developments | Low & Bonar (LWB LN) Tough H1 | ReNeuron Group (RENE LN) Exclusivity deal in ophthalmology, licensing deal expected in 2018 | Safestyle UK (SFE LN) Turnaround well underway but additional hit to profits and cash | Summit Therapeutics (SUMM LN) Grant award from CARB-X to support gonorrhoea programme | Swallowfield (SWL LN) Strong growth in Brands mitigates Manufacturing